Ritholtz Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.97M | Sell |
|
|||||
|
2025
Q1 | $7.24M | Sell |
|
|||||
|
2024
Q4 | $10.4M | Buy |
|
|||||
|
2024
Q3 | $14.1M | Buy |
|
|||||
|
2024
Q2 | $15.6M | Buy |
|
|||||
|
2024
Q1 | $14M | Buy |
|
|||||
|
2023
Q4 | $8.74M | Buy |
|
|||||
|
2023
Q3 | $7.45M | Sell |
|
|||||
|
2023
Q2 | $7.99M | Buy |
|
|||||
|
2023
Q1 | $7.74M | Buy |
|
|||||
|
2022
Q4 | $6.25M | Buy |
|
|||||
|
2022
Q3 | $3.51M | Buy |
|
|||||
|
2022
Q2 | $3.29M | Buy |
|
|||||
|
2022
Q1 | $2.74M | Buy |
|
|||||
|
2021
Q4 | $2.08M | Buy |
|
|||||
|
2021
Q3 | $1.46M | Buy |
|
|||||
|
2021
Q2 | $1.07M | Buy |
|
|||||
|
2021
Q1 | $660K | Buy |
|
|||||
|
2020
Q4 | $465K | Buy |
|
|||||
|
2020
Q3 | $414K | Buy |
|
|||||
|
2020
Q2 | $294K | Buy |
|